PMID- 35917689 OWN - NLM STAT- MEDLINE DCOM- 20220919 LR - 20220919 IS - 1873-4367 (Electronic) IS - 0927-7765 (Linking) VI - 218 DP - 2022 Oct TI - Nerve implants with bioactive interfaces enhance neurite outgrowth and nerve regeneration in vivo. PG - 112731 LID - S0927-7765(22)00414-3 [pii] LID - 10.1016/j.colsurfb.2022.112731 [doi] AB - Nerve implants functionalized with growth factors and stem cells are critical to promote neurite outgrowth, regulate neurodifferentiation, and facilitate nerve regeneration. In this study, human umbilical cord mesenchymal stem cells (hUCMSCs) and 3,4-hydroxyphenalyalanine (DOPA)-containing insulin-like growth factor 1 (DOPA-IGF-1) were simultaneously applied to enhance the bioactivity of poly(lactide-co-glycolide) (PLGA) substrates which will be potentially utilized as nerve implants. In vitro and in vivo evaluations indicated that hUCMSCs and DOPA-IGF-1 could synergistically regulate neurite outgrowth of PC12 cells, improve intravital recovery of motor functions, and promote conduction of nerve electrical signals in vivo. The enhanced functional and structural nerve regeneration of injured spinal cord might be mainly attributable to the synergistically enhanced biofunctionality of hUCMSCs and DOPA-IGF-1/PLGA on the bioactive interfaces. Findings from this study demonstrate the potential of hUCMSC-seeded, DOPA-IGF-1-modified PLGA implants as promising candidates for promoting axonal regeneration and motor functional recovery in spinal cord injury treatment. CI - Copyright (c) 2022 Elsevier B.V. All rights reserved. FAU - Wang, Zongliang AU - Wang Z AD - Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, PR China. FAU - Zhang, Yi AU - Zhang Y AD - Department of Urology, The Second Hospital, Jilin University, Changchun 130041, PR China. FAU - Wang, Liqiang AU - Wang L AD - Department of Ophthalmology, Third Medical Center, Chinese PLA General Hospital, Beijing 100853, PR China. FAU - Ito, Yoshihiro AU - Ito Y AD - Nano Medical Engineering Laboratory, RIKEN Cluster for Pioneering Research, Saitama 351-0198, Japan. FAU - Li, Gang AU - Li G AD - Department of Orthopaedics and Traumatology and Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region of China. FAU - Zhang, Peibiao AU - Zhang P AD - Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, PR China. Electronic address: zhangpb@ciac.ac.cn. LA - eng PT - Journal Article DEP - 20220727 PL - Netherlands TA - Colloids Surf B Biointerfaces JT - Colloids and surfaces. B, Biointerfaces JID - 9315133 RN - 34346-01-5 (Polyglactin 910) RN - 63-84-3 (Dihydroxyphenylalanine) RN - 67763-96-6 (Insulin-Like Growth Factor I) SB - IM MH - Animals MH - Dihydroxyphenylalanine MH - Humans MH - *Insulin-Like Growth Factor I/pharmacology MH - Nerve Regeneration/physiology MH - Neuronal Outgrowth MH - Polyglactin 910 MH - Rats MH - *Spinal Cord Injuries/metabolism/therapy OTO - NOTNLM OT - Bioactive interfaces OT - DOPA-IGF-1 OT - HUCMSCs OT - Implants OT - Neural regeneration COIS- Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2022/08/03 06:00 MHDA- 2022/09/20 06:00 CRDT- 2022/08/02 18:21 PHST- 2022/04/19 00:00 [received] PHST- 2022/07/08 00:00 [revised] PHST- 2022/07/25 00:00 [accepted] PHST- 2022/08/03 06:00 [pubmed] PHST- 2022/09/20 06:00 [medline] PHST- 2022/08/02 18:21 [entrez] AID - S0927-7765(22)00414-3 [pii] AID - 10.1016/j.colsurfb.2022.112731 [doi] PST - ppublish SO - Colloids Surf B Biointerfaces. 2022 Oct;218:112731. doi: 10.1016/j.colsurfb.2022.112731. Epub 2022 Jul 27.